3rd Quarter - Report

AMGEN, INC. for AMGEN INC

Firm
Client
Income
—
Expenses
$2,000,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Market Access and Intellectual Property (no specific bill)

LobbyistCovered position, as disclosed
VICTORIA BLATTER —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); Commerce, Dept of (DOC); Treasury, Dept of; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); White House Office; U.S. Trade Representative (USTR)

Taxation/Internal Revenue Code TAX

International tax issues, including: Tax Reform Puerto Rico Tax Incentives

LobbyistCovered position, as disclosed
VICTORIA BLATTER —
L NICOLE CURRIE —
REBECCA MANDELL —
NANCY ELLEN MCCARTHY —
WILLIAM O'BRIEN —
GREGORY PORTNER —
HELEN RHEE —

Contacted: White House Office; Natl Economic Council (NEC); Centers For Medicare and Medicaid Services (CMS); SENATE; Office of Management & Budget (OMB); Treasury, Dept of; HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Executive Office of the President (EOP); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

Medicare Part B (Average Sales Price) (Medicare Program Part B Drug Payment Model proposed rule) Medicare Part D rebates Coding and reimbursement for oncology drugs/biologics End Stage Renal Disease and issues related to dialysis S. 1827 KIDS Act of 2017 H.R. 849 Protecting Seniors' Access to Medicare Act of 2017

LobbyistCovered position, as disclosed
VICTORIA BLATTER —
L NICOLE CURRIE —
RUTH HOFFMAN —
JESSE KERNS —
REBECCA MANDELL —
HOWARD MOON —
WILLIAM O'BRIEN —
GREGORY PORTNER —
HELEN RHEE —

Contacted: Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); White House Office; U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Natl Economic Council (NEC); Health & Human Services, Dept of (HHS); Treasury, Dept of; Office of Management & Budget (OMB)

Bills named: H.R. 849 (115th), S. 1827 (115th)

Health Issues HCR

Biosimilars, no specific bill PDUFA, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA Health Resources and Services Administration (HRSA) policy regarding discounts on drugs used in the outpatient setting to help low-income/uninsured populations (340B), no specific bill

Contacted: U.S. Trade Representative (USTR); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Treasury, Dept of; White House Office; Commerce, Dept of (DOC); Natl Economic Council (NEC); SENATE; Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1245 (115th), S.Con.Res. 3 (115th), S. 469 (115th), H.R. 1628 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.